Assessment of Peripheral Endothelial Function in Idiopathic Pulmonary Fibrosis
NCT02594059 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43
Last updated 2021-03-17
Summary
The aim of the study is to assess the peripheral endothelial function in adult patients with idiopathic pulmonary fibrosis (IPF) and the relationship between the peripheral endothelial function and the severity of the IPF.
Conditions
Interventions
- OTHER
-
endothelial function
measure of reactive hyperemia-peripheral artery tone index
Sponsors & Collaborators
-
Hopital Foch
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-12-19
- Primary Completion
- 2020-07-15
- Completion
- 2020-07-15
Countries
- France
Study Locations
More Related Trials
-
Peripheral Endothelial Function in Asthmatic Patients
NCT02593344 ·Status: COMPLETED ·Phase: NA
-
Self-monitoring of Spirometry & Symptoms Via patientMpower App in Idiopathic Pulmonary Fibrosis
NCT03744598 ·Status: TERMINATED
-
Investigating Significant Health Trends in Idiopathic Pulmonary Fibrosis
NCT01695408 ·Status: COMPLETED
-
IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis
NCT02803580 ·Status: COMPLETED
-
Pulmonary Fibrosis Foundation Patient Registry
NCT02758808 ·Status: COMPLETED
-
Dyspnea and Idiopathic Pulmonary Fibrosis
NCT04864990 ·Status: COMPLETED
-
Idiopathic Pulmonary Fibrosis (IPF) and the 3 Minutes Sit-to-stand Test
NCT03268915 ·Status: COMPLETED ·Phase: NA
-
Pulmonary Fibrosis and Telomerase Mutation Study
NCT01501578 ·Status: COMPLETED
-
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
NCT01915511 ·Status: RECRUITING
-
Idiopathic Pulmonary Fibrosis Job Exposures Study
NCT03211507 ·Status: COMPLETED
-
Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)
NCT02719184 ·Status: COMPLETED
-
Observational Study to Evaluate Disease Course and Outcomes in Patients Treated With Esbriet (Pirfenidone) for Idiopathic Pulmonary Fibrosis (IPF) in Canada
NCT02552849 ·Status: COMPLETED
-
A Study to Test Different Imaging Techniques in Patients With Different Types of Interstitial Lung Disease
NCT05492994 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Pulmonary Care and Research Collaborative Patient Registry
NCT05445817 ·Status: UNKNOWN
-
Evaluation of Frailty in Patients With Fibrosing Interstitial Lung Diseases: Prognostic and Therapeutic Impact
NCT07004595 ·Status: NOT_YET_RECRUITING
-
Prospective Cohort of Patients With Fibrosing Interstitial Lung Disease Admitted for Acute Respiratory Failure
NCT06855004 ·Status: RECRUITING
-
PRospective Evaluation of Interstitial Lung DIsease Progression With Quantitative CT
NCT05609201 ·Status: ENROLLING_BY_INVITATION
-
Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England)
NCT01134822 ·Status: COMPLETED
-
Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China
NCT06655090 ·Status: RECRUITING
-
Screening Evaluation for Studies of Chronic Obstructive Pulmonary Disease (COPD)
NCT00889447 ·Status: COMPLETED
-
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
NCT01071707 ·Status: COMPLETED
-
Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in Nintedanib-treated Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) Patients
NCT05503030 ·Status: ACTIVE_NOT_RECRUITING
-
A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung Fibrosis
NCT07080125 ·Status: ACTIVE_NOT_RECRUITING
-
Non-interventional Study Describing Epidemiology, Prognosis and Patient Healthcare Costs in France, 2010-2017
NCT03858842 ·Status: UNKNOWN
-
Study of the Etiology and Immunological Pathogenesis in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF)
NCT02509364 ·Status: UNKNOWN